Monday was eventful for vaccine specialist Novavax (NASDAQ: NVAX), with several updates overshadowing good financial news for the company. Novavax's shares, consequently, ended the day 8.8% lower. The most immediate event for Novavax was actually a positive one.
Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting